New Product Puts RBCC On Leading Edge Of Organ Regeneration Research
2/18/2014 8:25:35 AM
MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--The 3D printing of functional human organs could be a reality within the next decade, and Rainbow Coral Corp. (OTCBB: RBCC) is helping to lead the bioprinting revolution now underway. Extremely promising breakthroughs in recent years have generated global interest in 3D bioprinting. Last August, Chinese researchers announced that they’d printed a small working kidney that lasted four months. In the U.S., researchers at Cornell University bioprinted a bionic ear last year, and San Diego firm Organovo showed promising results in printing human liver tissues.
Help employers find you! Check out all the jobs and post your resume.
comments powered by